171 related articles for article (PubMed ID: 17624855)
1. Biomarkers and surrogate end points in clinical trials of tuberculosis treatment.
Davies GR; Phillips PP; Nunn AJ
J Infect Dis; 2007 Aug; 196(4):648-9; author reply 649-50. PubMed ID: 17624855
[No Abstract] [Full Text] [Related]
2. Biomarkers for TB treatment response: challenges and future strategies.
Walzl G; Ronacher K; Djoba Siawaya JF; Dockrell HM
J Infect; 2008 Aug; 57(2):103-9. PubMed ID: 18649943
[TBL] [Abstract][Full Text] [Related]
3. The quest for biomarkers in tuberculosis.
Parida SK; Kaufmann SH
Drug Discov Today; 2010 Feb; 15(3-4):148-57. PubMed ID: 19854295
[TBL] [Abstract][Full Text] [Related]
4. Microbiologic surrogate end points in clinical trials of infectious diseases: example of acute otitis media trials.
Powers JH
Pharmacotherapy; 2005 Dec; 25(12 Pt 2):109S-123S. PubMed ID: 16305280
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers of treatment response in clinical trials of novel antituberculosis agents.
Perrin FM; Lipman MC; McHugh TD; Gillespie SH
Lancet Infect Dis; 2007 Jul; 7(7):481-90. PubMed ID: 17524807
[TBL] [Abstract][Full Text] [Related]
6. [Short-term chemotherapy in tuberculosis].
Ionescu C; Mihăescu T
Rev Med Chir Soc Med Nat Iasi; 1988; Suppl():35-41. PubMed ID: 3075796
[No Abstract] [Full Text] [Related]
7. Timing of relapse after cessation of anti-tuberculosis chemotherapy.
Rieder HL
Int J Tuberc Lung Dis; 2010 Jul; 14(7):928. PubMed ID: 20550782
[No Abstract] [Full Text] [Related]
8. Doctors report breakthrough antibiotic treatment for TB.
AIDS Read; 2007 Nov; 17(11):528, 534. PubMed ID: 18167636
[No Abstract] [Full Text] [Related]
9. Gradual filling up of TB drug pipeline: how can we play our role better?
Kant L
Indian J Tuberc; 2009 Jan; 56(1):1-4. PubMed ID: 19402265
[No Abstract] [Full Text] [Related]
10. Tuberculosis drug serum levels.
Peloquin CA
Clin Infect Dis; 2001 Aug; 33(4):584-5. PubMed ID: 11462203
[No Abstract] [Full Text] [Related]
11. [Contribution of the Sanatório Santa Tereza, State of Guanabara, to trials on the standard chemotherapy of untreated tuberculosis patients].
Lisboa RM
Rev Bras Med; 1965 Aug; 22(8):481-5. PubMed ID: 5322119
[No Abstract] [Full Text] [Related]
12. A lesson to be learned.
Kanyok T
Int J Tuberc Lung Dis; 1997 Dec; 1(6):490-2. PubMed ID: 9487444
[No Abstract] [Full Text] [Related]
13. The assessment of new anti-tuberculosis drugs for a paediatric indication.
Donald PR
Int J Tuberc Lung Dis; 2007 Nov; 11(11):1162-5. PubMed ID: 17958976
[TBL] [Abstract][Full Text] [Related]
14. Developing drugs for tuberculosis.
Farlow A
Science; 2007 Feb; 315(5815):1076-7; author reply 1076-7. PubMed ID: 17322043
[No Abstract] [Full Text] [Related]
15. Reducing relapse in tuberculosis treatment: is it time to reassess WHO treatment guidelines?
Johnston JC; Khan FA; Dowdy DW
Int J Tuberc Lung Dis; 2015 Jun; 19(6):624. PubMed ID: 25946348
[No Abstract] [Full Text] [Related]
16. Biological surrogate end-points in cancer trials: potential uses, benefits and pitfalls.
Cooper R; Kaanders JH
Eur J Cancer; 2005 Jun; 41(9):1261-6. PubMed ID: 15939261
[TBL] [Abstract][Full Text] [Related]
17. Development of rifapentine: the way ahead.
Mitchison DA
Int J Tuberc Lung Dis; 1998 Aug; 2(8):612-5. PubMed ID: 9712273
[No Abstract] [Full Text] [Related]
18. Long term follow up of HIV-infected patients with tuberculosis treated with 6-month intermittent short course chemotherapy.
Swaminathan S; Deivanayagam CN; Rajasekaran S; Venkatesan P; Padmapriyadarsini C; Menon PA; Ponnuraja C; Dilip M
Natl Med J India; 2008; 21(1):3-8. PubMed ID: 18472696
[TBL] [Abstract][Full Text] [Related]
19. Relation between recurrence of tuberculosis and transitional changes in IFN-γ release assays.
Kaneko Y; Nakayama K; Kinoshita A; Kurita Y; Odashima K; Saito Z; Yoshii Y; Horikiri T; Seki A; Seki Y; Takeda H; Kuwano K
Am J Respir Crit Care Med; 2015 Feb; 191(4):480-3. PubMed ID: 25679108
[No Abstract] [Full Text] [Related]
20. Medicine. A portfolio model of drug development for tuberculosis.
Glickman SW; Rasiel EB; Hamilton CD; Kubataev A; Schulman KA
Science; 2006 Mar; 311(5765):1246-7. PubMed ID: 16513969
[No Abstract] [Full Text] [Related]
[Next] [New Search]
